Altria Group Inc (NYSE:MO) shares are trading higher on Tuesday after the first-quarter full-year 2025 earnings.
The company reported a first-quarter FY25 sales decline of 5.7% year-on-year to $5.26 billion, beating the analyst consensus estimate of $4.62 billion.
The decrease in revenue was primarily driven by lower net revenues in the smokeable products segment.
Revenue for smokeable products decreased by 5.8%, and oral tobacco products grew by 0.5%.
Smokeable products segment reported domestic cigarette shipment volume decrease of 13.7%, with Marlboro down 13.3%.
Gross profit fell 0.9% Y/Y to $3.24 billion. The operating income for the quarter plunged by 32.9% to $1.88 billion.
Also Read: Royal Caribbean Cruises’ Q1 Benefits From Strong Demand, Stock Surges
Adjusted EPS of $1.23 beat the consensus estimate of $1.18. Altria paid dividends of $1.7 billion in the first quarter.
In the first quarter of 2025, the company repurchased 5.7 million shares at an average price of $56.97, for a total cost of $326 million.
As of March 31, 2025, Altria had $674 million remaining under the current authorized $1 billion share repurchase program, which is expected to be completed by the end of December.
Altria held $4.72 billion in cash and equivalents as of March-end and the total debt of Altria amounted to $26.05 billion.
"Our highly profitable traditional tobacco businesses performed well in a challenging environment in the first quarter," said CEO Billy Gifford.
Outlook: Altria raised FY25 adjusted EPS guidance from $5.22–$5.37 to $5.30–$5.45 versus an estimate of $5.32.
This represents a growth rate of 2% to 5% from a base of $5.19 in 2024.
MO Price Action: Altria shares traded higher by 0.82% at $58.66 at last check on Tuesday.
Read Next: • Meta, Booz Allen Launch ‘Space Llama’ AI System For Space Station Operations
Photo: NguyeningMedia via Shutterstock
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.